Daily Equity Reports
-
Upload
epic-research -
Category
Documents
-
view
216 -
download
1
description
Transcript of Daily Equity Reports
-=6 HEADLINES
Indian Market
Indian equity markets up by 0.27%
Nifty up by 16.25 pts and settle at 6009.50
Sensex up by 50.54 pts at 19764.78
Bank Nifty down by 8.65 pts at 12778.20
Global Market
European markets were up with FTSE down by 9.43 closed at 6017,CAC down by 20.18 closed at 3713 and DAX down by 25.01 closed at 7753.
Dow future was down 20.00 closed at
13311.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY NEWSLETTER
4TH JANUARY 2013
HEADLINES
• Offtake target bigger challenge than
production: Coal India
• Govt may consider ordinance for
Hindustan Zinc stake sale
• IGL keen to buy ADB stake in Petronet
LNG
• Dr Reddy's Laboratories launches hair
loss tablets in US
FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 3-Jan-13 3089.48 1692.11 1397.37
DII 3-Jan-13 996.46 1902.42 -905.96
NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6097 6066 6035 6022 6004 5991 5973 5942 5911
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
The 50-unit S&P CNX Nifty moved past the psychological 6,000 level as key benchmark indices eked
out small gains. The barometer index, BSE Sensex, was provisionally up 38.66 points or 0.2%, up
59.61 points from the day's low and off 33.40 points from the day's high. The market breadth,
indicating the overall health of the market, was positive. Index heavyweight Reliance Industries (RIL)
extended intraday gains in late trade.
The BSE Sensex was up 38.66 points or 0.2% to 19,752.90.
The S&P CNX Nifty was up 12.15 points or 0.2% to 6,005.40.
Among the 30-share Sensex pack, 17 declined while the rest of them gained.
IT pivotals rose after US lawmakers early this week reached a last-minute deal to avert the fiscal cliff.
US is the biggest outsourcing market for the Indian IT firmsIT major Tata Consultancy Services rose
1.5%.India's third largest software services exporter by revenues Wipro gained 0.83%.Shares of
banking giant State Bank of India (SBI) gained 0.88% to Rs 2,469.75 after striking a 52-week high of
Rs 2,482.20 in intraday today, 3 January 2013. Dr Reddy's Laboratories advanced 2.35% after the
company said it has launched Finasteride Tablets 1 mg in the US market.
STOCKS TO WATCH
CROMPTON
ADANI
BHEL
PFC
SCRIPS IN BAN PERIOD
SUZLON
09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Consolidate
Strategy: Buy on dips
Support: 5970
Resistance: 6060
BANK NIFTY
Bank Nifty looks Consolidate
Strategy: Buy on dips
Support: 12700
Resistance: 12840
.0
GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH AMTEK S NOT
EXECUTED
CASH ZEE
ENTERTAINMENT B
TGT ACHEIVED
FUTURE ADANI
ENTERPRISE B
NOT EXECUTED
FUTURE HCL
TECHNOLOGIES S
NOT EXECUTED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
Dr Reddys
Lab 1882.30 584.79 1837.70 44.60 2.43
Cairn India
327.50 2442.67 320.00 7.50 2.34
Bharti Airtel
328.00 3677.59 321.05 6.95 2.16
ONGC 279.80 4215.38 274.60 5.20 1.89
DLF 238.90 5511.61 235.20 3.70 1.57
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
Tata Power
110.15 1607.01 112.00 -1.85 -1.65
Lupin 608.85 475.31 614.90 -6.05 -0.98
PNB 896.80 587.50 905.50 -8.70 -0.96
Sun Pharma
Inds. 733.85 520.44 740.90 -7.05 -0.95
Hero MotoCorp
1887.95 334.61 1905.35 -17.40 -0.91
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
BHARTI AIRTEL BUY 328.90 330.90 333.90 326.90
ICICI BANK SELL 1168.00 1158.00 1145.00 1178.00
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
ALLAHBAD BANK BUY 181.30 182.30 183.80 180.30
ADANI ENETERPRISES
SELL 282.00 281.00 279.50 283.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.